About the Authors
- Jasimuddin Ahamed
-
* E-mail: jahamed@rockefeller.edu
Affiliation Laboratory of Blood and Vascular Biology, The Rockefeller University, New York, New York, United States of America
- Christin A. Janczak
-
Affiliation Laboratory of Blood and Vascular Biology, The Rockefeller University, New York, New York, United States of America
- Knut M. Wittkowski
-
Affiliation Laboratory of Blood and Vascular Biology, The Rockefeller University, New York, New York, United States of America
- Barry S. Coller
-
Affiliation Laboratory of Blood and Vascular Biology, The Rockefeller University, New York, New York, United States of America
Competing Interests
BSC is an inventor of abciximab (Centocor), and in accord with federal law and the policies of the Research Foundation of the State University of New York, he has a royalty interest in abciximab. He is also an inventor of the VerifyNow assay system (Accumetrics), and in accord with federal law and the policies of the Mount Sinai School of Medicine he has a royalty interest in the VerifyNow assay system (Accumetrics). In addition he is a consultant to Accumetrics and is an inventor on a pending patent for a new antiplatelet compound. JA is an inventor of a patent technology application of the Scripps Research Institute (Patent Applications Serial Nos. TSRI 1146) “Specific Inhibitory Strategies for Signaling Tissue Factor”, and in accord with federal law and the policies of the Scripps Research Institute, he has a royalty interest in licensing this technology to Centocor.
Author Contributions
Conceived and designed the experiments: JA BSC. Performed the experiments: JA. Analyzed the data: JA BSC. Contributed reagents/materials/analysis tools: JA BSC. Wrote the paper: JA BSC. Performed the thrombosis model, collection of samples and assisted with experimental design: CAJ. Designed statistical analyses and assisted with interpretation of the data: KMW.